Dr. Alexander Spira, MD
Claim this profileVirginia Cancer Specialists
About Alexander Spira, MD
Education:
- Earned an MD from New York University School of Medicine.
- Received a PhD from the New York School of Arts and Sciences.
Experience:
- Completed an internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania.
- Undertook a medical oncology fellowship at Johns Hopkins Hospital.
- Serves as Director of the Virginia Cancer Specialists Research Institute and the Phase I Trial Program.
- Holds positions as Clinical Assistant Professor and Assistant Professor of Oncology at Johns Hopkins School of Medicine.
- Actively involved in leadership roles within the USOncology network, including Co-Chair of the Thoracic Oncology Committee.
Area of expertise
Non-Small Cell Lung Cancer
Alexander Spira, MD has run 62 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Solid Tumors
Alexander Spira, MD has run 57 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Virginia Cancer Specialists
Virginia Cancer Specialists, PC
Clinical Trials Alexander Spira, MD is currently running
TNG462
for Solid Cancers
This trial is testing a new oral drug called TNG462 in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these cancer cells grow. The goal is to see if TNG462 can stop the cancer from growing and spreading.
Recruiting
1 award
Phase 1 & 2
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting
1 award
Phase 1
2 criteria
More about Alexander Spira, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 139 trials as a Principal Investigator · 37 Active Clinical Trials
Treatments Alexander Spira, MD has experience with
- Pembrolizumab
- Nivolumab
- Docetaxel
- Avutometinib (VS-6766)
- Gemcitabine
- Placebo
Breakdown of trials Alexander Spira, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander Spira, MD specialize in?
Alexander Spira, MD focuses on Non-Small Cell Lung Cancer and Solid Tumors. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Alexander Spira, MD currently recruiting for clinical trials?
Yes, Alexander Spira, MD is currently recruiting for 36 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Alexander Spira, MD has studied deeply?
Yes, Alexander Spira, MD has studied treatments such as Pembrolizumab, Nivolumab, Docetaxel.
What is the best way to schedule an appointment with Alexander Spira, MD?
Apply for one of the trials that Alexander Spira, MD is conducting.
What is the office address of Alexander Spira, MD?
The office of Alexander Spira, MD is located at: Virginia Cancer Specialists, Fairfax, Virginia 22031 United States. This is the address for their practice at the Virginia Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.